secwatch.observer — SEC 8-K summary
======================================

Issuer:     Evofem Biosciences, Inc. (EVFM)
CIK:        0001618835
Form:       8-K
Filed at:   2024-11-25T23:59:59+00:00
Accession:  0001493152-24-047613
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Evofem extends merger outside date with Aditxt to Jan 31, 2025
--------------------------------------------------------------

- Fourth Amendment to Amended and Restated Merger Agreement dated Nov 19, 2024.
- Changes required consummation date from Nov 29, 2024 to Jan 31, 2025.
- Amendment modifies only Section 8.1(b)(ii); all other terms unchanged.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1618835/000149315224047613/0001493152-24-047613-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1618835/000149315224047613/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-047613

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer